Dr. Michael W. Lin, MD

Dr. Lin practices at Acuity Eye Group - Trinity Surgical Solutions in Lancaster, California.

Dr. Lin's NPI, 1285661819, was assigned on June 27, 2006. Dr. Lin graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1995. Dr. Lin holds California license A60921.

Dr. Lin's primary practice is Acuity Eye Group - Trinity Surgical Solutions, at 44815 Fig Avenue, Suite 100, Lancaster, CA 93534. The practice phone is (626) 479-8383. Dr. Lin also practices at Trinity Surgical Solutions, Inc, 207 S Santa Anita St, San Gabriel, CA 91776.

Dr. Lin's primary practice is Acuity Eye Group - Trinity Surgical Solutions in Lancaster, California. Dr. Lin is also affiliated with AHMC San Gabriel Valley Medical Center. Dmand AI also links Dr. Lin to 3 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 6 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Lin is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Lin is licensed in California.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, fluid and electrolyte imbalances, hypercalcemia, osteoporosis, overactive thyroid and parathyroid gland disorder among the conditions Dr. Lin treats.

CMS data shows 2,435 Medicare services from Dr. Lin across 9 procedure codes in 2024, for 1,132 Medicare patients. Medicare paid $253,860 for them.

CMS counts 1,132 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 489 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 62% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 67, with 73% women.

In 2024, Dr. Lin wrote 16,678 Medicare Part D claims for 1,403 patients. 48% of them were for generic drugs. CMS names the drug for 16,269 of them, across 116 drugs with 11 or more claims each, at $4,595,415 in total drug cost. In 2023, CMS named 18,674 claims across 112 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Lin for performance year 2024, reported individually. Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 54 general payments to Dr. Lin from 15 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 89% of the total. Abbott Laboratories paid the most, $220.

Dr. Lin graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1995.

Dr. Lin is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.